NephroGenex Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
NephroGenex Inc prices initial public offering of common stock
NephroGenex Inc:Announced the pricing of its initial public offering of 3,100,000 shares of its common stock at an initial public offering price of $12.00 per share.Says the gross proceeds to NephroGenex is expected to be $37,200,000 before underwriting discounts and commissions and other offering expenses.Says all of the common stock is being offered by NephroGenex and in addition, NephroGenex has granted the underwriters a 45-day option to purchase up to an additional 465,000 shares of common stock from NephroGenex to cover over-allotments, if any.Says NephroGenex's common stock has been approved for listing on the NASDAQ Capital Market and is expected to begin trading under the ticker symbol NRX on Feb. 11, 2014.Says the offering is expected to close on Feb. 14, 2014.Says Aegis Capital Corp. is acting as sole book-running manager for the offering.
Latest Developments for NephroGenex Inc
- Share this
- Digg this